Literature DB >> 29607107

Tumor spread through air space, the clinical implications for T factor and effects on the disease recurrence and prognosis.

Takahiro Nakajima1, Junichi Morimoto1, Ichiro Yoshino1.   

Abstract

Year:  2018        PMID： 29607107      PMCID： PMC5864657          DOI： 10.21037/jtd.2018.01.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Hajime Maeda; Akihide Matsumura; Mitsunori Ohta; Meinoshin Okumura
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.

Authors:  Satoshi Shiono; Naoki Yanagawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-06-26

3.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

4.  Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.

Authors:  Ho Yun Lee; So Won Lee; Kyung Soo Lee; Ji Yun Jeong; Joon Young Choi; O Jung Kwon; So Hee Song; Eun Young Kim; Jhingook Kim; Young Mog Shim
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

5.  Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-18       Impact factor: 5.209

6.  Protein overexpression and gene amplification of cellular mesenchymal-epithelial transition factor is associated with poor prognosis in micropapillary-predominant subtype pulmonary adenocarcinoma.

Authors:  Jing Zhang; Jian Sun; Zhiwen Zhang; Xiaolong Liang; Yufeng Luo; Shafei Wu; Zhiyong Liang
Journal:  Hum Pathol       Date:  2017-11-09       Impact factor: 3.466

Review 7.  Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?

Authors:  Lucio Buffoni; Tiziana Vavalà; Silvia Novello
Journal:  Curr Treat Options Oncol       Date:  2016-10

Review 8.  Radiologic implications of the 2011 classification of adenocarcinoma of the lung.

Authors:  John H M Austin; Kavita Garg; Denise Aberle; David Yankelevitz; Keiko Kuriyama; Hyun-Ju Lee; Elisabeth Brambilla; William D Travis
Journal:  Radiology       Date:  2012-10-15       Impact factor: 11.105

9.  Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer.

Authors:  Kyohei Masai; Hiroyuki Sakurai; Aoi Sukeda; Shigeki Suzuki; Keisuke Asakura; Kazuo Nakagawa; Hisao Asamura; Shun-Ichi Watanabe; Noriko Motoi; Nobuyoshi Hiraoka
Journal:  J Thorac Oncol       Date:  2017-09-04       Impact factor: 15.609

10.  Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Gerard A Silvestri; Anne V Gonzalez; Michael A Jantz; Mitchell L Margolis; Michael K Gould; Lynn T Tanoue; Loren J Harris; Frank C Detterbeck
Journal:  Chest       Date:  2013-05       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.